Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Basal profiles of male and female residents with or without development of CKD

From: Gender difference in relationship between body mass index and development of chronic kidney disease

  Men Women
Development of CKD (−) (+) (−) (+)
n 306 167 734 299
Age (years) 58.0 ±11.5 64.6 ± 8.9** 56.2 ± 10.6 59.6 ± 11.1**
Body mass index (kg/m2) 22.8 ± 2.9 23.4 ± 3.0* 22.1 ± 3.0 23.0 ± 3.2**
Obesity (%) 21.6 28.1 16.5 24.1**
Systolic blood pressure (mmHg) 124 ± 18 132 ± 18** 122 ± 17 125 ± 18**
Diastolic blood pressure (mmHg) 76 ± 11 78 ± 10* 73 ± 10 74 ± 10
Total cholesterol (mg/dL) 195 ± 32 194 ± 34 205 ± 33 207 ± 34
HDL-cholesterol (mg/dL) 57 ± 15 56 ± 15 64 ± 15 62 ± 15
Triglyceride (mg/dL) 106 ± 73 103 ± 52 88 ± 45 94 ± 56
Fasting blood glucose (mg/dL) 93 ± 15 97 ± 17* 90 ± 12 90 ± 10
AST (IU/L) 26 ± 8 27 ± 11 22 ± 7 24 ± 9*
ALT (IU/L) 24 ± 13 26 ± 22 18 ± 10 20 ± 17
γ-GTP (IU/L) 43 ± 50 58 ± 96 21 ± 22 22 ± 21
Creatinine (mg/dl) 0.71 ± 0.09 0.78 ± 0.12** 0.51 ± 0.08 0.59 ± 0.09**
  1. AST, aspartate aminotransferase; ALT, alanine aminotransferase; GTP, glutamyl transpeptidase; means ± S.D.; *P < 0.05, **P < 0.01, vs. without development of CKD.